Published date: 16 January 2018
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Research and development services and related consultancy services - 73000000
Location of contract
North East
Value of contract
£1,000,000
Procurement reference
NCL001-DN240581-25120291
Published date
16 January 2018
Closing date
31 March 2017
Contract start date
13 June 2017
Contract end date
13 June 2022
Contract type
Service contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The scope of this contract relates specifically to the Phase 2b Randomized, Double-blind, Parallel Placebo- and Active-controlled Study to Assess the Efficacy and Safety of Vamorolone in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) and the extension study that will follow this. A registered Clinical Trial Unit (CTU) or Contracted Research Organisation (CRO) is required to set up and manage the clinical trial at sites in [UK/Australia/Israel/Sweden]. The CTU / CRO will be carrying out delegated duties on behalf of the sponsor, ReveraGen, but will be receiving payments for these duties from the Vision-DMD Horizon 2020 grant, coordinated by Newcastle University. The contract will begin on award and end in November 2019 and be followed by an extenstion study. This contract consists of 4 separate geographical Lots:
Lot 1: UK
Lot 2: Australia
Lot 3: Israel
Lot 4: Sweden
More information
Links
Award information
Awarded date
19 December 2017
Contract start date
3 January 2018
Contract end date
31 May 2021
Total value of contract
£1,139,000
This contract was awarded to 4 suppliers.
PSR Group B V
Address
Planetenweg 5, Hoofddorp, 2132 HN, Netherlands
Reference
None
Supplier is SME?
Yes
Supplier is VCSE?
No
Gothia Forum for Clinical Research
Address
Grona Straket 12, Gothenburg, 41345, Sweden
Reference
None
Supplier is SME?
Yes
Supplier is VCSE?
No
Novotech
Address
Level 3, 235 Pyrmont Street, New South Wales, 2009 Australia
Reference
None
Supplier is SME?
No
Supplier is VCSE?
No
TCA Clinical research Ltd
Address
Pob 504, Florantine 5, Tzur Moshe, 4281000 Israel
Reference
None
Supplier is SME?
Yes
Supplier is VCSE?
No
About the buyer
Contact name
Gillian Mournian
Address
Newcastle University
King's Gate
Newcastle upon Tyne
NE1 7RU
United Kingdom
Telephone
+44 1912226073
Website
Share this notice
Closing: 31 March 2017
All content is available under the
